Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2019	$ 859,578	$ 106,742	$ 784,885	$ (32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(53,744)		(53,744)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	5,779	389	5,390
Stock-based compensation expense	5,367		5,367
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(1,482)	(20)	(1,462)
Other comprehensive income	(1,653)			(1,653)
Net earnings	168,537		168,537
Balance at end of period at May. 01, 2020	984,950	107,111	911,541	(33,702)
Balance at beginning of period at Jan. 31, 2020	912,050	106,977	837,194	(32,121)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,888)		(26,888)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	1,637	136	1,501
Stock-based compensation expense	1,407		1,407
Purchase of common stock	(121)	(2)	(119)
Other comprehensive income	(1,581)			(1,581)
Net earnings	98,446		98,446
Balance at end of period at May. 01, 2020	984,950	107,111	911,541	(33,702)
Balance at beginning of period at Oct. 31, 2020	1,114,828	107,583	1,041,507	(34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(56,602)		(56,602)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	9,380	523	8,857
Stock-based compensation expense	10,345		10,345
Contribution of stock to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(108,321)	(1,086)	(107,235)
Other comprehensive income	4,850			4,850
Net earnings	253,452		253,452
Balance at end of period at Apr. 30, 2021	1,229,417	107,043	1,151,786	(29,412)
Balance at beginning of period at Jan. 29, 2021	1,179,722	107,613	1,104,285	(32,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,191)		(28,191)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	3,151	173	2,978
Stock-based compensation expense	5,829		5,829
Purchase of common stock	(76,029)	(743)	(75,286)
Other comprehensive income	2,764			2,764
Net earnings	142,171		142,171
Balance at end of period at Apr. 30, 2021	$ 1,229,417	$ 107,043	$ 1,151,786	$ (29,412)